Atorvastatin Calcium
Product Images NDC 60760-593

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 60760-593). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ator (Atorvastation 60760 593 30)

Atorvastatin Calcium Tablets USP 10 mg blister pack label showing quantity of 30 tablets. Label states the NDC 60760-593-30 and is packaged by St. Mary's Medical Park Pharmacy, Oro Valley, AZ. Manufactured by Gravili Pharmaceuticals Pvt. Ltd., Telangana, India. The label includes storage instructions to store at controlled room temperature 15° to 30°C (59° to 86°F) and directions to use as directed.*

FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 01)

Chemical structure diagram of atorvastatin calcium, showing the molecular arrangement including phenyl rings, fluorine, hydroxyl groups, and calcium ions with associated water molecules.*

FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 02)

A line graph showing cumulative incidence (%) over time in years for Atorvastatin versus placebo. The solid line represents Atorvastatin and the dashed line represents placebo, with Atorvastatin showing a lower cumulative incidence over 3.5 years. Hazard ratio (HR) and p-value are noted at the bottom right.*

FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 03)

A cumulative hazard plot showing the time to first primary endpoint over four years of follow-up, comparing atorvastatin and placebo groups. The y-axis represents cumulative hazard percentage, and the x-axis represents years, with atorvastatin showing a lower cumulative hazard than placebo.*

FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 04)

A line chart depicting the time to first major cardiovascular endpoint over five years for subjects taking atorvastatin at doses of 10 mg and 80 mg. The vertical axis shows the percentage of subjects experiencing the event. The chart includes a hazard ratio (HR) of 0.78 with a confidence interval of 0.69 to 0.89 and a p-value of 0.0002, comparing the two dosages.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.